series-b
Stage
1
Investors
About
Immunophotonics develops therapeutics using a proprietary glycan polymer platform designed to stimulate antigen capture and immune responses to treat cancer and other diseases.
Explore Immunophotonics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.